The latest research & treatment news about Hepatitis C infection, diagnosis, symptoms and treatment.
When added to conventional antiviral therapy, GlobeImmune's investigational, therapeutic Hepatitis C vaccine appears to correct a fundamental deficit in cellular immunity in those with the disadvantaged T/T allele of the IL-28 gene.
Continue reading »Large doses of Vitamin A could boost Hepatitis C combination therapy's effectiveness - but could it also cause further damage to the liver?
Continue reading »Hepatitis C antiviral therapy had been reserved primarily for those in the earlier stages of liver disease. However, new research suggests that those with a certain type of cirrhosis should begin treatment as well.
Continue reading »Although criteria for determining which medical institutions made this list are not included, these 10 Hepatitis C treatment centers are touted as the best nationwide.
Continue reading »By engineering mice livers to contain enough human cells, researchers at the Salk Institute for Biological Studies are making progress in the quest to find better therapeutic solutions for many ailments, including Hepatitis C.
Continue reading »Helping to bring a new level of understanding to the Hepatitis C virus (HCV), a University of Alberta study found that this infection can affect neural cells. Besides helping explain some common Hepatitis C symptoms, these findings could pave the way for a new frontier in HCV treatment.
Continue reading »November is National Diabetes Awareness Month. By analyzing relevant research, it appears that diabetes prevention efforts may protect Hepatitis C previous non-responders from developing liver cancer.
Continue reading »By combining three immune strengthening approaches along with five natural ways to ease cold and flu symptoms, discover how those with Hepatitis C can safely get through this year's cold and flu season.
Continue reading »Since having Hepatitis C can increase one's sensitivity to a toxic drug interaction, those with the virus must become their own health advocate.
Continue reading »Previously known as viramidine, taribavirin is less able to enter red blood cells than ribavirin. When substituted for ribavirin during Hepatitis C combination therapy, researchers found that appropriate dosing of taribavirin reduced the anemia rate while increasing the treatment's efficacy.
Continue reading »Inside you'll discover:
You'll also receive the latest news and information to support liver health.
Rest assured, we will not rent your email to anyone.
You should receive your email with links to the reports shortly. If you do not, please check your spam/junk folder.
If you still haven't received our email after a few minutes, please feel free to contact us.
Close Window
